NCT06649916 Word Learning From Parentese in Autistic Children
| NCT ID | NCT06649916 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Texas at Dallas |
| Condition | Autism |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-10-04 |
| Primary Completion | 2028-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2024-10-04 with a primary completion date of 2028-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overall objective of this research is to determine whether parentese delivered in the video format (Aim 1) and in live interaction (Aim 2) facilitates novel word learning in autistic children and to investigate if there are factors that influence the effect of parentese on word learning (Aim 3).
Eligibility Criteria
Inclusion Criteria: * children with or without a diagnosis of ASD between 18 and 59 months Exclusion Criteria: * hears another language more than 10% of time based on parent report * has uncorrected visual impairment or hearing impairment * has developmental disorders or medical conditions other than ASD that affect language or cognition (excepting psychiatric conditions often comorbid with ASD such as ADHD)
Contact & Investigator
Pumpki L. Su, PhD
PRINCIPAL INVESTIGATOR
The University of Texas at Dallas
Frequently Asked Questions
Who can join the NCT06649916 clinical trial?
This trial is open to participants of all sexes, aged 18 Months or older, up to 59 Months, studying Autism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06649916 currently recruiting?
Yes, NCT06649916 is actively recruiting participants. Contact the research team at lei.su@utdallas.edu for enrollment information.
Where is the NCT06649916 trial being conducted?
This trial is being conducted at Richardson, United States.
Who is sponsoring the NCT06649916 clinical trial?
NCT06649916 is sponsored by The University of Texas at Dallas. The principal investigator is Pumpki L. Su, PhD at The University of Texas at Dallas. The trial plans to enroll 100 participants.